NCT04594837

Brief Summary

The randomized study (in Phase II of the U44) compares the efficacy and durability of 9 weeks (18 sessions) of robot-assisted physical therapy (PTR) versus physical therapy (PT) alone on foot drop as assessed by gait biomechanics (ankle angle at initial contact, peak swing ankle angle, number of heel-first strikes - % total steps, gait velocity) and blinded clinician assessment (dorsiflexion active range of motion, ankle muscle strength, assistive device needs).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 20, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 14, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 20, 2020

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
Last Updated

January 26, 2023

Status Verified

January 1, 2023

Enrollment Period

4.5 years

First QC Date

October 14, 2020

Last Update Submit

January 24, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Angle at Initial Contact

    Angle at initial contact averaged across each gait cycle for each subject at a given testing time point.

    Change from Baseline at both 9 Weeks and at 21 Weeks

  • Swing Dorsiflexion

    Peak swing dorsiflexion averaged across each gait cycle for each subject at a given testing time point.

    Change from Baseline at both 9 Weeks and at 21 Weeks

  • Number of Heel-First Foot Strikes

    Number of heel-first foot strikes for each subject at a given testing time point.

    Change from Baseline at both 9 Weeks and at 21 Weeks

  • Gait Velocity

    Average gait velocity (meters/second) for each subject at a given testing time point.

    Change from Baseline at both 9 Weeks and at 21 Weeks

Secondary Outcomes (12)

  • Active range of motion for Dorsiflexion

    Change from Baseline at both 9 Weeks and at 21 Weeks

  • Ankle Muscle Strength

    Change from Baseline at both 9 Weeks and at 21 Weeks

  • Number of Participants Using Assistive Devices and Ankle Foot Orthoses

    Change from Baseline at both 9 Weeks and at 21 Weeks

  • Dynamic Gait Index

    Change from Baseline at both 9 Weeks and at 21 Weeks

  • Berg Balance Scale

    Change from Baseline at both 9 Weeks and at 21 Weeks

  • +7 more secondary outcomes

Study Arms (4)

PTR (Physical Therapy while wearing Robot group) (Phase II)

EXPERIMENTAL

Subjects receive 18 one-hour PT training sessions over 9 weeks while wearing the robot initially parameterized to individual deficit severity. Subjects perform over-ground mobility tasks of increasing challenge with robotic assist, as needed. Training is generally divided into 3 phases based on individual ability to address gait deficits, postural transitions, physical demand and environmental terrain.

Device: PTR Physical Therapy while wearing Robot group (Phase II)

PT (Physical Therapy Only) (Phase II)

ACTIVE COMPARATOR

Subjects receive 18 one-hour PT training sessions over 9 weeks. Subjects perform over-ground mobility tasks of increasing challenge with therapist assist, as needed. Training is generally divided into 3 phases based on individual ability to address gait deficits, postural transitions, physical demand and environmental terrain.

Other: Physical Therapy Only (Phase II)

X-PTR, Cross over group for Physical Therapy n Sub-Acute group.

EXPERIMENTAL

Participants enrolled in the physical therapy only group will be given the option to re-enroll as a cross over participant to receive 18 one-hour PT training sessions over 9 weeks while wearing the robot initially parameterized to individual deficit severity. Subjects perform over-ground mobility tasks of increasing challenge with robotic assist, as needed. Training is generally divided into 3 phases based on individual ability to address gait deficits, postural transitions, physical demand and environmental terrain.

Device: Cross over group for Physical Therapy n Sub-Acute group. (Phase II)

C-PTR, Chronic Stroke Subjects to receive robotic gait training therapy.

EXPERIMENTAL

Chronic stroke subjects receive 18 one-hour PT training sessions over 9 weeks while wearing the robot initially parameterized to individual deficit severity. Subjects perform over-ground mobility tasks of increasing challenge with robotic assist, as needed. Training is generally divided into 3 phases based on individual ability to address gait deficits, postural transitions, physical demand and environmental terrain.

Device: Chronic Stroke Subjects to receive robotic gait training therapy.

Interventions

Subjects receive 18 one-hour PT training sessions over 9 weeks while wearing the robot initially parameterized to individual deficit severity. Subjects perform over-ground mobility tasks of increasing challenge with robotic assist, as needed. Training is generally divided into 3 phases based on individual ability to address gait deficits, postural transitions, physical demand and environmental terrain.

Also known as: PTR
PTR (Physical Therapy while wearing Robot group) (Phase II)

Subjects receive 18 one-hour PT training sessions over 9 weeks. Subjects perform over-ground mobility tasks of increasing challenge with therapist assist, as needed. Training is generally divided into 3 phases based on individual ability to address gait deficits, postural transitions, physical demand and environmental terrain.

Also known as: PT
PT (Physical Therapy Only) (Phase II)

Participants enrolled in the physical therapy only group will be given the option to re-enroll as a cross over participant to receive 18 one-hour PT training sessions over 9 weeks while wearing the robot initially parameterized to individual deficit severity. Subjects perform over-ground mobility tasks of increasing challenge with robotic assist, as needed. Training is generally divided into 3 phases based on individual ability to address gait deficits, postural transitions, physical demand and environmental terrain.

Also known as: X-PTR
X-PTR, Cross over group for Physical Therapy n Sub-Acute group.

Chronic stroke subjects receive 18 one-hour PT training sessions over 9 weeks while wearing the robot initially parameterized to individual deficit severity. Subjects perform over-ground mobility tasks of increasing challenge with robotic assist, as needed. Training is generally divided into 3 phases based on individual ability to address gait deficits, postural transitions, physical demand and environmental terrain.

Also known as: C-PTR
C-PTR, Chronic Stroke Subjects to receive robotic gait training therapy.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 18 and older
  • In the subacute phase of stroke recovery (\>6 weeks to \<6 months post-stroke) with residual hemiparesis of the lower extremity that includes symptoms of foot-drop. - or - In the chronic phase of stroke recovery (\>6 months post-stroke) with residual hemiparesis of the lower extremity that includes symptoms of foot-drop.
  • Clear indications of hemiparetic gait by clinical observation

You may not qualify if:

  • Cardiac history of (a) unstable angina, (b) recent (less than 3 months) myocardial infarction, congestive heart failure (NYHA category II); (c) hemodynamically significant valvular dysfunction
  • Hypertension that is a contraindication for routine physical therapy (greater than 160/100 on two assessments).
  • Medical History: (a) recent hospitalization (less than 3 months) for severe medical disease, (b) symptomatic peripheral arterial occlusive disease, (c) orthopedic or chronic pain conditions that significantly alter gait function, (d) pulmonary or renal failure (e) active cancer
  • History of non-stroke neuromuscular disorder restricting gait.
  • Aphasia or cognitive functioning that confounds participation, defined as unable to follow 2 step commands or judgment of the medical officer or therapist.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Maryland Rehabilitation & Orthopaedic Institute

Baltimore, Maryland, 21207, United States

RECRUITING

Related Publications (2)

  • Roy A, Hennessie B, Hafer-Macko C, Forrester LW, Westlake K, Macko RF. Adaptive control ankle robotics training durably improves gait biomechanics in chronic hemiparetic stroke and footdrop. J Neuroeng Rehabil. 2025 Dec 29. doi: 10.1186/s12984-025-01834-2. Online ahead of print. No abstract available.

  • Roy A, Hennessie B, Hafer-Macko C, Westlake K, Macko R. Dorsiflexion Specific Ankle Robotics to Enhance Motor Learning After Stroke: A Preliminary Report. Res Sq [Preprint]. 2024 Jun 25:rs.3.rs-4390770. doi: 10.21203/rs.3.rs-4390770/v1.

MeSH Terms

Conditions

Peroneal NeuropathiesStrokeParesis

Interventions

Clinical Trials, Phase II as Topic

Condition Hierarchy (Ancestors)

MononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Clinical Trials as TopicClinical Studies as TopicEpidemiologic Study CharacteristicsEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Brad Hennessie, MHA, MBA

    NextStep Robotics Inc.

    STUDY DIRECTOR

Central Study Contacts

Richard Macko, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2020

First Posted

October 20, 2020

Study Start

August 20, 2020

Primary Completion

February 28, 2025

Study Completion

February 28, 2025

Last Updated

January 26, 2023

Record last verified: 2023-01

Locations